"C0909381"^^ . "Cytomegalovirus retinitis"^^ . . . "An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir.NCI-GLOSS" . "Valganciclovir"^^ . "Pharmacologic Substance"^^ . . "38289"^^ . "Valganciclovir"^^ . "38289"^^ . . "ValganciclovirPTNCI" . "A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. (NCI04)NCI" . "L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl EsterSNNCI" . "FDA"^^ . . "Nucleic Acid, Nucleoside, or Nucleotide"^^ . "C2629"^^ . . "GCU97FKN3R"^^ . . "VALGANCICLOVIRPTFDAGCU97FKN3R" . "CHEBI:63635"^^ . "Valganciclovir"^^ . "175865-60-8"^^ . . "valganciclovirPTNCI-GLOSSCDR0000045013" . "Cytomegalovirus infections; multicentric Castleman's disease; non-HIV-associated Kaposis sarcoma"^^ .